Clinical Trial Update: Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating colecalciferol as an add-on therapy to subcutaneously administered interferon-beta-1b for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon beta-1b (Interferon beta-1b)
• colecalciferol (vitamin D3)

Snippet

Sponsor: University of Turku | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED